| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $411.8M | +17.5% |
| Cost of Revenue | $269.5M | +20.5% |
| Gross Profit | $142.3M | +12.1% |
| R&D Expense | $23.7M | +29.0% |
| SG&A Expense | $90.5M | +10.2% |
| Operating Income | -$1.9M | +10.0% |
| Pre-tax Income | $15.7M | +42.0% |
| Income Tax | $6.0M | -14.0% |
| Net Income | $9.7M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $342.1M | +2.2% |
| Accounts Receivable | $79.5M | +14.6% |
| Current Assets | $439.5M | +3.8% |
| Total Assets | $612.9M | +3.5% |
| Current Liabilities | $52.1M | -6.2% |
| Total Liabilities | $70.8M | -4.8% |
| Stockholders' Equity | $542.1M | +4.7% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $40.6M | +34.4% |
| Capital Expenditures | $15.3M | +30.3% |
| Investing Cash Flow | -$15.1M | +70.5% |
| Financing Cash Flow | -$19.9M | -119.7% |
| Free Cash Flow | $25.3M | +37.1% |
| +139.2% |
| EPS (Basic) | $0.11 | +120.0% |
| EPS (Diluted) | $0.11 | +120.0% |